High-dose therapy and autologous stem cell rescue for patients with Hodgkin’s disease in first relapse after chemotherapy: results from the EBMT

@article{Sweetenham1997HighdoseTA,
  title={High-dose therapy and autologous stem cell rescue for patients with Hodgkin’s disease in first relapse after chemotherapy: results from the EBMT},
  author={Jw Sweetenham and Goli Taghipour and D. Milligan and A K Blystad and Dolores Caballero and Athanasios Fassas and A H Goldstone and on behalf of the Lymphoma Working Party of the Europe Transplantation},
  journal={Bone Marrow Transplantation},
  year={1997},
  volume={20},
  pages={745-752}
}
The purpose of this study was to investigate the results of high-dose therapy and autologous stem cell transplantation in adult patients with Hodgkin’s disease in first relapse after chemotherapy, to determine the overall and progression-free survival, identify prognostic factors for outcome, and to define the role of conventional dose salvage therapy given prior to the high dose regimen. A retrospective analysis of 139 adult patients reported to the lymphoma registry of the European Group for… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 18 CITATIONS

References

Publications referenced by this paper.
SHOWING 1-10 OF 21 REFERENCES

An update on the Vancouver experi- randomised trial.Lancet1993;341: 1051–1054. ence in the management of advanced Hodgkin’s

P Klimo, JM Connors
  • 1993

High - dose therapy and treated with the MOPP / ABV hybrid program

T Philip, JO Armitage, G Spitzer
  • Lancet
  • 1993

Treatment of relapsed Hodgkin ’ s plete observations

EL Kaplan, P Meier, JA Radford, D Crowther
  • Exp Hematol
  • 1992

505–509. factors after the first relapse of Hodgkin’s disease

WS Velasquez, F Cabanillas, P Salvador
  • 1991

Effective salpatients

WS Velasquez, F Cabanillas, P Salvador
  • Ann Oncol
  • 1991